发明名称 Neuro-progenitor produced from an SCNT-derived ES cell
摘要 An embryonic stem cell line derived from a nucleus-transferred oocyte prepared by transferring a nucleus of a human somatic cell into an enucleated human oocyte may differentiate into various desired cell types.
申请公布号 US9476064(B2) 申请公布日期 2016.10.25
申请号 US201314091106 申请日期 2013.11.26
申请人 H BION CO., LTD. 发明人 Roh Sung-Il;Hwang Woo-Suk;Lee Byeong-Chun;Kang Sung-Keun;Ryu Young-June;Lee Eu-Gene;Kim Soon-Woong;Kwon Dae-Kee;Kwon Hee-Sun;Koo Ja-Min;Park Eul-Soon;Hwang Youn-Young;Yoon Hyun-Soo;Park Jong-Hyuk;Kim Sun-Jong
分类号 C12N15/00;C12N15/87;C12N5/0735;C12N15/877;C12N5/0797;C12N5/0793 主分类号 C12N15/00
代理机构 Rothwell, Figg, Ernst & Manbeck, P.C. 代理人 Rothwell, Figg, Ernst & Manbeck, P.C.
主权项 1. A method for preparing a neuro progenitor, comprising the steps of: (1) culturing a human somatic cell to prepare a nuclear donor cell; (2) enucleating a human oocyte to prepare a recipient oocyte; (3) preparing a nucleus-transferred oocyte by transferring a nucleus of the nuclear donor cell into the recipient oocyte and fusing the nucleus of the nuclear donor cell and the recipient oocyte; (4) subjecting the nucleus-transferred oocyte to reprogramming, activation and in vitro culturing to form a blastocyst; (5) isolating an inner cell mass from the blastocyst and culturing the inner cell mass in an undifferentiated state to establish the embryonic stem cell line deposited under the accession number of KCLRF-BP-00092; (6) culturing the embryonic stem cell line to form an embryoid body; (7) culturing the embryoid body in the presence of an agent suitable for differentiating a cell of the embryoid body into the neuro progenitor; and (8) selecting a cell expressing a marker of the neuro progenitor and culturing the selected cell to obtain the neuro progenitor, wherein step (4) is performed by reprogramming the nucleus-transferred oocyte for a time period of up to 3 hours, treating the nucleus-transferred oocyte with a calcium ionophore at a concentration ranging from 6 μM to 15 μM and subsequently with 6-dimethylaminopurine at a concentration ranging from 1.5 mM to 2.5 mM, and sequentially culturing the nucleus-transferred oocyte in vitro in the G1.2 medium and the SNUnt-2 medium.
地址 Seoul KR